Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients

CALRmutations in myeloproliferative neoplasms: Hidden behind the reticulum

(2014) Paola Guglielmelli et al.   AMERICAN JOURNAL OF HEMATOLOGY

CALR mutations and a new diagnostic algorithm for MPN

(2014) Ayalew Tefferi et al.   Nature Reviews Clinical Oncology

Crucial Role for Endoplasmic Reticulum Stress During Megakaryocyte Maturation

(2013) Jose J. Lopez et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia

(2013) G. Rotunno et al.   BLOOD

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

(2013) E. Rumi et al.   BLOOD

Calreticulin for better or for worse, in sickness and in health, until death do us part

(2013) Paul Eggleton et al.   CELL CALCIUM

Mutations and prognosis in primary myelofibrosis

(2013) A M Vannucchi et al.   LEUKEMIA

Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2

(2013) J. Nangalia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

(2013) Thorsten Klampfl et al.   NEW ENGLAND JOURNAL OF MEDICINE

A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

(2012) F. Passamonti et al.   BLOOD

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD